These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 16417952

  • 1. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N, Sinha R, Balfour G, Booy R.
    Vaccine; 2006 Mar 24; 24(14):2544-9. PubMed ID: 16417952
    [Abstract] [Full Text] [Related]

  • 2. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.
    Keyserling H, Papa T, Koranyi K, Ryall R, Bassily E, Bybel MJ, Sullivan K, Gilmet G, Reinhardt A.
    Arch Pediatr Adolesc Med; 2005 Oct 24; 159(10):907-13. PubMed ID: 16203934
    [Abstract] [Full Text] [Related]

  • 3. Immune memory in children previously vaccinated with an experimental quadrivalent meningococcal polysaccharide diphtheria toxoid conjugate vaccine.
    Pichichero M, Papa T, Blatter M, Mitchell D, Kratz R, Sneed J, Bassily E, Casey J, Gilmet G.
    Pediatr Infect Dis J; 2006 Nov 24; 25(11):995-1000. PubMed ID: 17072120
    [Abstract] [Full Text] [Related]

  • 4. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.
    Int J Infect Dis; 2008 May 24; 12(3):278-88. PubMed ID: 17981067
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
    Halperin SA, McDonald J, Samson L, Danzig L, Santos G, Izu A, Smith B, MacDonald N.
    Clin Invest Med; 2002 Dec 24; 25(6):243-51. PubMed ID: 12516995
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.
    Chandramohan D, Hodgson A, Coleman P, Baiden R, Asante K, Awine E, Owusu-Agyei S, Boutriau D, Nelson CB, Greenwood B.
    Vaccine; 2007 Sep 03; 25 Suppl 1():A83-91. PubMed ID: 17521782
    [Abstract] [Full Text] [Related]

  • 7. Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.
    Campbell JD, Edelman R, King JC, Papa T, Ryall R, Rennels MB.
    J Infect Dis; 2002 Dec 15; 186(12):1848-51. PubMed ID: 12447774
    [Abstract] [Full Text] [Related]

  • 8. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA, Greenberg DP, Hedrick J, Pichichero M, Decker MD, Saunders M.
    Vaccine; 2016 Oct 17; 34(44):5273-5278. PubMed ID: 27642132
    [Abstract] [Full Text] [Related]

  • 9. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B.
    J Infect Dis; 2001 Jan 01; 183(1):97-104. PubMed ID: 11087205
    [Abstract] [Full Text] [Related]

  • 10. Effects of prior polysaccharide vaccination on magnitude, duration, and quality of immune responses to and safety profile of a meningococcal serogroup C tetanus toxoid conjugate vaccination in adults.
    Southern J, Deane S, Ashton L, Borrow R, Goldblatt D, Andrews N, Balmer P, Morris R, Kroll JS, Miller E.
    Clin Diagn Lab Immunol; 2004 Nov 01; 11(6):1100-4. PubMed ID: 15539513
    [Abstract] [Full Text] [Related]

  • 11. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J, Nolan T, Richmond P, Reynolds G, Nissen M, Lambert SB, Marshall H, Papa T, Rehm C.
    Pediatr Infect Dis J; 2012 Jan 01; 31(1):e15-23. PubMed ID: 22094636
    [Abstract] [Full Text] [Related]

  • 12. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
    Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, Gilmet G, Papa T.
    Pediatr Infect Dis J; 2005 Jan 01; 24(1):57-62. PubMed ID: 15665711
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children.
    Granoff DM, Morgan A, Welsch JA.
    Vaccine; 2005 Jul 29; 23(34):4307-14. PubMed ID: 15921829
    [Abstract] [Full Text] [Related]

  • 14. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.
    Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C, Poolman J, Boutriau D.
    Vaccine; 2007 Dec 12; 25(51):8487-99. PubMed ID: 17996996
    [Abstract] [Full Text] [Related]

  • 15. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.
    Rennels M, King J, Ryall R, Papa T, Froeschle J.
    Pediatr Infect Dis J; 2004 May 12; 23(5):429-35. PubMed ID: 15131466
    [Abstract] [Full Text] [Related]

  • 16. The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine.
    Dbaibo G, Van der Wielen M, Reda M, Medlej F, Tabet C, Boutriau D, Sumbul A, Anis S, Miller JM.
    Int J Infect Dis; 2012 Aug 12; 16(8):e608-15. PubMed ID: 22704725
    [Abstract] [Full Text] [Related]

  • 17. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.
    J Am Geriatr Soc; 2004 Nov 12; 52(11):1883-7. PubMed ID: 15507066
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC, Moro M, Ruiz-Contreras J, Castro J, Gómez-Campderá JA, Navarro ML, Merino JM, Martín-Ancel A, Roca J, García-del-Río M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Boceta R, García-Corbeira P, Jacquet JM, Collard A, Schuerman L, Spanish DTaP-HBV-IPV-097 Study Group.
    Pediatr Infect Dis J; 2006 Aug 12; 25(8):713-20. PubMed ID: 16874171
    [Abstract] [Full Text] [Related]

  • 19. Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults.
    Kshirsagar N, Mur N, Thatte U, Gogtay N, Viviani S, Préziosi MP, Elie C, Findlow H, Carlone G, Borrow R, Parulekar V, Plikaytis B, Kulkarni P, Imbault N, LaForce FM.
    Vaccine; 2007 Sep 03; 25 Suppl 1():A101-7. PubMed ID: 17532101
    [Abstract] [Full Text] [Related]

  • 20. Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants.
    Schmitt HJ, Steul KS, Borkowski A, Ceddia F, Ypma E, Knuf M.
    Vaccine; 2008 Apr 24; 26(18):2242-52. PubMed ID: 18407386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.